Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5146
Abstract: To describe the effect that validation of venous thromboembolism (VTE) coded entries in the health improvement network (THIN) has on incidence rates of VTE among a cohort of rivaroxaban/warfarin users. read more here.
Keywords: validation venous; improvement network; rivaroxaban warfarin; health improvement ... See more keywords
Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.02.001
Abstract: BACKGROUND There are limited data regarding clinical outcomes and healthcare resource utilization of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) who are morbidly obese (body mass index >40 kg/m2 or body weight… read more here.
Keywords: warfarin; obese patients; atrial fibrillation; morbidly obese ... See more keywords
Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Haematology"
DOI: 10.1111/ejh.13185
Abstract: To assess the association between rivaroxaban and warfarin and major bleeding risk in unprovoked venous thromboembolism (VTE) patients. read more here.
Keywords: venous thromboembolism; rivaroxaban warfarin; major bleeding; unprovoked venous ... See more keywords
Management of Venous Thromboembolism in Morbid Obesity With Rivaroxaban or Warfarin
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221089008
Abstract: Background Rivaroxaban is a first-line option for the management of venous thromboembolism (VTE). However, limited data are available regarding its effectiveness in morbidly obese patients. Objective To evaluate rates of thrombosis and bleeding in morbidly… read more here.
Keywords: management venous; receiving rivaroxaban; venous thromboembolism; rivaroxaban warfarin ... See more keywords
Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Epidemiology"
DOI: 10.2147/clep.s383996
Abstract: Acute kidney injury (AKI) has been associated with use of oral anticoagulants (OACs) in patients with non-valvular atrial fibrillation (NVAF). We aimed to compare AKI risk among users of rivaroxaban vs. warfarin. We identified two… read more here.
Keywords: acute kidney; kidney injury; rivaroxaban warfarin; method ... See more keywords
Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.978639
Abstract: Introduction The efficacy and safety of antithrombotic strategies remain uncertain in patients with atrial fibrillation undergoing lower-extremity revascularisation. Materials and methods Between January 2011 and November 2021, 319 patients with atrial fibrillation after lower-extremity revascularisation… read more here.
Keywords: efficacy; rivaroxaban warfarin; safety; atrial fibrillation ... See more keywords